| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,589 |
2,581 |
$99K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
999 |
835 |
$32K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,420 |
580 |
$13K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
846 |
530 |
$9K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
323 |
177 |
$9K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
398 |
214 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
659 |
563 |
$7K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
167 |
167 |
$6K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
126 |
94 |
$4K |
| 81001 |
|
492 |
387 |
$1K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
151 |
83 |
$184.17 |
| 36415 |
Collection of venous blood by venipuncture |
66 |
59 |
$130.41 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
304 |
228 |
$109.84 |
| 90688 |
|
12 |
12 |
$93.30 |
| 99000 |
|
231 |
223 |
$0.00 |
| 99072 |
|
376 |
347 |
$0.00 |